Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism.

American Journal of Physiology. Heart and Circulatory Physiology
Rajesh H AminTodd Leff

Abstract

In experimental animal and cell culture models, activation of peroxisome proliferator-activated receptor (PPAR) gamma in heart has been shown to have beneficial effects on cardiac function and cardiomyocyte physiology. The goal of this study was to identify the signaling pathway by which PPARgamma activation protects cardiomyocytes from the deleterious effects of hypertrophic stimuli. In primary cardiomyocyte cultures, we found that genetic or pharmacological activation of PPARgamma protected cells from cardiac hypertrophy induced by alpha-adrenergic stimulation. Examination of gene expression in these cells revealed a surprising increase in the expression of adiponectin in cardiomyocytes and secretion of the high-molecular-weight form of the hormone into media. Using RNAi to block PPARgamma-induced adiponectin production or adiponectin receptor gene expression, we found that the PPARgamma-mediated anti-hypertrophic effect required cardiomyocyte-produced adiponectin, as well as an intact adiponectin signaling pathway. Furthermore, mice expressing constitutive-active PPARgamma and cardiomyocyte specific adiponectin expression were protected from high-fat diet-induced cardiac hypertrophy and remodeling. These findings demonstrate...Continue Reading

References

Nov 10, 1995·The Journal of Biological Chemistry·P E SchererH F Lodish
Apr 13, 1999·The American Journal of Physiology·R H RitchieR J Schiebinger
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y T ZhouR H Unger
Apr 17, 2002·Circulation·Martin E YoungHeinrich Taegtmeyer
Nov 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Eva TomasNeil B Ruderman
Nov 20, 2003·Nature Medicine·Andrea L HevenerJerrold Olefsky
Nov 24, 2004·Nature Medicine·Rei ShibataKenneth Walsh
Jan 13, 2005·Canadian Journal of Physiology and Pharmacology·Quy N DiepErnesto L Schiffrin
Jan 27, 2005·The Journal of Pharmacology and Experimental Therapeutics·Reeba K VikramadithyanIra J Goldberg
Feb 25, 2005·American Journal of Physiology. Endocrinology and Metabolism·Bong-Soo ChaRobert R Henry
Mar 31, 2005·American Journal of Physiology. Endocrinology and Metabolism·Leonard S GolfmanHeinrich Taegtmeyer
Apr 19, 2005·Journal of Lipid Research·Yuchang FuW Timothy Garvey
Feb 9, 2006·American Journal of Physiology. Endocrinology and Metabolism·Nathan K LeBrasseurEva Tomas
Apr 6, 2006·Annals of Internal Medicine·Jonathan M McGavockUNKNOWN American College of Physicians and the American Physiological Society
May 23, 2007·The New England Journal of Medicine·Steven E Nissen, Kathy Wolski
Jun 27, 2007·Circulation·Sihem Boudina, E Dale Abel
Sep 8, 2007·The Journal of Clinical Investigation·Ni-Huiping SonIra J Goldberg
Apr 9, 2008·European Heart Journal·Carsten SkurkWolfgang Poller

❮ Previous
Next ❯

Citations

Aug 16, 2012·Heart Failure Reviews·Min Park, Gary Sweeney
Jul 22, 2015·Journal of Molecular and Cellular Cardiology·Keith DadsonGary Sweeney
Jul 19, 2014·Internal and Emergency Medicine·Tiziana Di ChiaraGiuseppe Licata
Sep 29, 2011·Journal of Molecular and Cellular Cardiology·Min DingKathleen A Martin
Jan 5, 2017·Canadian Journal of Physiology and Pharmacology·Nicholas ArnoldLakshmi Pulakat
Feb 28, 2017·Scientific Reports·Raphaël BoursereauSonia M Brichard
Feb 22, 2017·Journal of Molecular Endocrinology·Hui WangJingang Zheng
Jan 3, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Aimin Xu, Paul M Vanhoutte
Sep 11, 2012·Molecular and Cellular Biochemistry·Abd Al Rahman Al-ShudiefatPawan K Singal
Feb 20, 2015·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Mikaela A LuiGraham R Scott
Jun 27, 2019·PloS One·Patricia M DennisHayley Murphy
Jun 23, 2020·Oxidative Medicine and Cellular Longevity·Crystal M GhantousAsad Zeidan
Apr 5, 2011·British Journal of Pharmacology·Xiaoyan HuiAimin Xu
Apr 28, 2021·Cell & Bioscience·Bipradas Roy, Suresh Selvaraj Palaniyandi
May 4, 2011·Biochemical Pharmacology·Alex Morrison, Ji Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.